Work

Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

Year: 2012

Type: review

Abstract: Article Tools Review Articles Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2012.41.6768 Journal of Clinical Oncology - published online before print August 13, 2012 PMID: 22891271 Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia Hagop KantarjianxHagop KantarjianSearch for articles by this author , Deborah ThomasxDeborah ThomasSearch for articles by this author , Alan S. WaynexAlan S. WayneSearch for articles by this author , Susan O'BrienxSusan O'BrienSearch for articles by this author Show More Hagop Kantarjian, Deborah Thomas, and Susan O'Brien, MD Anderson Cancer Center, Houston, TX; and Alan S. Wayne, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. https://doi.org/10.1200/JCO.2012.41.6768 First Page Full Text PDF Figures and Tables © 2012 by American Society of Clinical Oncology

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.41.6768

Authors: Hagop Kantarjian, Deborah Thomas, Alan S. Wayne, Susan O'Brien

Institutions: National Institutes of Health, The University of Texas MD Anderson Cancer Center, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, Sanofi, National Institutes of Health, National Cancer Institute